Talabostat, fibroblast activation protein inhibitor, attenuates inflammation and fibrosis in systemic sclerosis

Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, VARGA J (2015) Systemic sclerosis. Nat Rev Dis Prim 1:1–21. https://doi.org/10.1038/nrdp.2015.2

Article  Google Scholar 

Ayers NB, Sun CM, Chen SY (2018) Transforming growth factor-β signaling in systemic sclerosis. J Biomed Res 32:3–12. https://doi.org/10.7555/JBR.31.20170034

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnes TC, Anderson ME, Moots RJ (2011) The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol. https://doi.org/10.1155/2011/721608

Article  PubMed  PubMed Central  Google Scholar 

Dziankowska-Bartkowiak B, Zebrowska A, Joss-Wichman E, Kobos J, Waszczykowska E (2006) Expression of metalloproteinases and their inhibitors in skin lesions of systemic sclerosis ]}}});">Buy article PDF 39,95 €

Comments (0)

No login
gif